Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
University of Nebraska
Natera, Inc.
Novartis
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Guardant Health, Inc.
Columbia University
University of Arizona
Tempus AI
Stanford University
Stanford University
Taproot Health
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Institut de Cancérologie de Lorraine
Abramson Cancer Center at Penn Medicine
SpeciCare
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
CureOne
Stanford University
Wake Forest University Health Sciences
Cancer Trials Ireland
University of Washington
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Delcath Systems Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center